Why swine flu virus develops drug resistance

   May 30, 2:50 pm

Washington, May 30 (ANI): Using computer chips of a type more commonly found in games consoles , researchers have revealed how the swine flu virus resists anti-flu drugs like Relenza and Tamiflu.

Professor Adrian Mulholland and Dr Christopher Woods from Bristol's School of Chemistry, together with colleagues in Thailand, used graphics processing units (GPUs) to simulate the molecular processes that take place when these drugs are used to treat the H1N1-2009 strain of influenza - commonly known as 'swine flu'.

Their results provide new insight that could lead to the development of the next generation of antiviral treatments for flu.

H1N1-2009 is a new, highly adaptive virus derived from different gene segments of swine, avian, and human influenza.

Within a few months of its appearance in early 2009, the H1N1-2009 strain caused the first flu pandemic of the 21st-century.

The antiviral drugs Relenza and Tamiflu, which target the neuraminidase (NA) enzyme, successfully treated the infection but widespread use of these drugs has led to a series of mutations in NA that reduce the drugs' effectiveness.

Clinical studies indicate that the double mutant of swine flu NA known as IRHY2 reduced the effectiveness of Relenza by 21 times and Tamiflu by 12,374 times - that is, to the point where it has become an ineffective treatment.

To understand why the effectiveness of Relenza and Tamiflu is so seriously reduced by the occurrence of this mutation, the researchers performed long-timescale molecular dynamics (MD) simulations using GPUs.

"Our simulations showed that IRHY became resistant to Tamiflu due to the loss of key hydrogen bonds between the drug and residues in a part of the NA's structure known as the '150-loop'," Professor Mulholland said.

"This allowed NA to change from a closed to an open conformation. Tamiflu binds weakly with the open conformation due to poor electrostatic interactions between the drug and the active site, thus rendering the drug ineffective," Professor Mulholland added.

These findings suggest that drug resistance could be overcome by increasing hydrogen bond interactions between NA inhibitors and residues in the 150-loop, with the aim of maintaining the closed conformation.

The study has been published in Biochemistry. (ANI)

Dawn of Antarctic ozone hole `healing` Jul 1, 12:28 pm
Washington D.C, Jul 1 (ANI): We are finally seeing a glimmer of good news for environment: ozone damage is on the mend!
Full Story
Turns out, revenge's a 'bittersweet' symphony Jun 30, 7:23 am
Washington D.C, Jun 30 (ANI): To get past it or to get even, that is the question. Now, a recent study has suggested that an eye for an eye can end up making us celebrating and feeling worse at the same time.
Full Story
We evolved 3 times faster post dino extinction Jun 29, 9:03 am
Washington D.C, Jun 29 (ANI): According to a new study, our ancestors evolved three times faster in the 10 million years after the extinction of the dinosaurs than in the previous 80 million years.
Full Story
Global variations in malaria parasites revealed Jun 28, 1:20 pm
Washington D.C, Jun 28 (ANI): A team of scientists has found that the malaria parasite Plasmodium vivax is evolving rapidly to adapt to conditions in different geographical locations.
Full Story
Comments